Oncology

Syapse, a precision oncology startup, revealed the names of six new hospital participants in its data-sharing network during the Biden Cancer Summit in Washington, D.C., Sept. 21.

Precision medicine has the potential to transform cancer care, but challenges need to be addressed. Here’s what more than 160 oncologists nationwide said about their aspirations and hesitations for these targeted therapies. Editor's Note: This post originally appeared on Cardinal…

Royal Philips will integrate clinical pathways from Boston-based Dana-Farber Cancer Institute into its Philips IntelliSpace Oncology Platform to provide physicians with clinical decision support related to cancer care management, the healthcare technology company announced May 31.

Navican, a genomics research and testing company affiliated with Salt Lake City-based Intermountain Healthcare, will roll out a precision cancer care service dubbed TheraMap.

Positive developments in the late-stage trials for Merck's Keytruda immunotherapy lung cancer treatment led the company's stock to spike nearly 4 percent April 9, according to Fortune.

Cota completed its Series C investment round with $40 million in funding, the New York City-based healthcare analytics startup confirmed Feb. 21.

Syapse, a precision medicine solutions provider and Medidata, a provider of cloud-based technology and data analytics for clinical research, are joining forces.

Salt Lake City-based Intermountain Healthcare plans to offer hereditary cancer gene panels through the Intermountain Precision Genomics Core Laboratory in St. George, Utah, the health system announced Feb. 1.

Syapse, an oncology-focused precision medicine company, entered into a multiyear strategic collaboration with Roche.

Memorial Sloan Kettering Cancer Center (New York). Memorial Sloan Kettering Cancer Center, a nationally recognized cancer center, is the oldest and largest private cancer hospital in the world. At Sloan Kettering, the multidisciplinary disease management teams provide comprehensive care to breast cancer…